# Lysogene

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lysogene-s-a

- Industry: Biotechnology
- Headquarters: France
- Website: www.lysogene.com
- Total disclosed funding: $23M
- Latest round: Series A (May 21, 2014)
- Investors on record: 3

## About

Lysogene S.A. is a biopharmaceutical company focused on developing innovative gene therapies for rare neurodegenerative diseases, aiming to address significant unmet medical needs.Founded in 2009 and headquartered in France, Lysogene S.A. specializes in gene therapy research, particularly targeting rare neurological disorders. The company has undergone pivotal developments in its strategic direction. Karen Aiach, the founder and current CEO, has previously operated in other ventures within the life sciences sector. In February 2017, Lysogene raised EUR 22.6 million in an IPO, selling 12.08 million shares at EUR 6.8 per share, marking a significant financial milestone for the firm. The company has completed a total of 7 deals to date.Lysogene S.A. focuses on developing gene therapies to treat severe neurodegenerative diseases, leveraging advanced genetic technologies. Its product pipeline includes therapies designed to address conditions that currently lack effective treatments, with a strong emphasis on the development of innovative solutions for patients.In the most recent fiscal year of 2021, Lysogene reported a revenue of USD 4.41 mn, with an EBITDA loss of USD 15.29 mn, reflecting the company's ongoing investment in research and development.Lysogene plans to enhance its product offerings with new gene therapy candidates aimed at treating rare neurological disorders, with specific candidates expected to launch in the coming years. The company is targeting expansion into European and North American markets by 2025. The recent funding raised in February 2017 will be pivotal in supporting these development and market expansion initiatives.

## Funding rounds

- Series A, May 21, 2014, $23M — Sofinnova Partners, Bpifrance Investissement, Novo Seeds

## Investors

- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series A
- Bpifrance Investissement (https://capitalatlas.ai/funds/bpifrance-investissement) — Series A
- Novo Seeds — Series A